SpaceX OpenAI Potential IPO Valuations Could Surpass Berkshire Hathaway Polymarket Suggests Legislators and Insurers Blamed for Worsening Trucking Industry Challenges Pfizer Clinches Trademark Victory in Singapore Against Merck Over Vaccine Brand Morgan Stanley Adjusts Edison International Price Target Following April Utility Sector Assessment Top CD Rates on May 23 2026 Leading Account Offers 4 APY Amid Changing Rate Landscape Sebi Exposes Alleged PumpandDump Scheme Across 82 SME Stocks Impounds Rs 2025 Crore Ovintiv Inc OVV Q1 2026 Earnings EPS Beats Estimates Amid Solid Execution Cactus Inc WHD Q1 2026 Earnings EPS Beat Fails to Boost Sentiment as Shares Slip CVNA Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Uncertainty Nortech Systems NSYS Q3 2025 Earnings Loss Per Share Reported Amid Modest Stock Gain Satellos Bioscience Q1 2026 Earnings Narrower Loss Reported Stock Slips on Lack of Revenue Progress DGICA Q1 2026 Earnings EPS Falls Short of Estimates Gulfport Energy GPOR Stays Near 178 as Momentum Fades Slightly Amid Sector Headwinds Jones Lang LaSalle JLL Holds Steady Near Support as Volume Remains Subdued Hub Cyber Security Warrants HUBCW Slide 1773 as Price Holds at 001 Level Top Wealth Group Holding TWG Holds Near Support Amid Slight Decline TryHard Holdings THH Jumps 74 Testing Key Resistance at 038 Indian Equity Indices Edge Higher Sensex Gains 230 Points Nifty 50 Closes Above 23700 as Banking Stocks Outperform CRMD Q1 2026 Earnings Earnings Surge as EPS Beats Estimates by 3172 Idaho Strategic Resources IDR Surges 434 as Momentum Builds Toward Key Resistance Persistent Inflation Pressures Beyond Energy Where Consumers Face Rising Costs Cancer Treatment Costs Surge ACA May Offer Limited Relief Amid Rising Expenses SEC Postpones Proposed Exemptions for Tokenized Stock Trading Sources Say Barclays and Citi Adjust Shopify Price Targets Following Q1 Earnings Report Ofcom Flags Safety Concerns Over TikTok and YouTube for Younger Audiences AI Rally Powers RecordBreaking Run for Global Momentum Stocks Eli Lillys Retatrutide Shows Strong Phase 3 Data Adding WeightLoss Pipeline Momentum